公司資料
Salarius Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- SLRX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for SLRX.
公司概覽
業務概覽
Salarius Pharmaceuticals is a biotechnology company focused on oncology and epigenetic or related cancer biology. Its story is built around seeking targeted cancer therapies for difficult tumors.
所在地與產業分類
Salarius is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商業模式特徵
The company depends on clinical data, partnership options, and capital discipline. Investors usually track early readouts and whether the pipeline can maintain enough momentum to matter.
生技產業定位
Salarius occupies a catalyst-sensitive oncology niche within biotech. The stock is driven by proof-of-concept and the market's confidence in the company's cancer thesis.
未來催化劑
- Salarius is a legacy / closeout story now, so the catalysts are any remaining strategic or asset-resolution update rather than a live oncology milestone. The market is mainly focused on residual value.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。